Desq Long
Sign in

Company

PALVELLA THERAPEUTICS, INC.

PVLA · CIK 0001583648

SEC FORM 4
$15,458.10

PALVELLA THERAPEUTICS, INC. (PVLA)

Acquisition (code M) of 2,165 shares at $7.14 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code M

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001104659-26-118466 · filed 2026-10-23 · View filing →

SEC FORM 4
$19,503.84

PALVELLA THERAPEUTICS, INC. (PVLA)

Acquisition (code M) of 2,148 shares at $9.08 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code M

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001104659-26-118466 · filed 2026-10-23 · View filing →

SEC FORM 4
$252,558.52

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 2,043 shares at $123.6214 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001104659-26-118466 · filed 2026-10-23 · View filing →

SEC FORM 4
$208,148.56

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,663 shares at $125.1645 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001104659-26-118466 · filed 2026-10-23 · View filing →

SEC FORM 4
$76,600.30

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 607 shares at $126.1949 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001104659-26-118466 · filed 2026-10-23 · View filing →

SEC FORM 4
$57,662.78

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 476 shares at $121.1403 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$254,058.49

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 2,072 shares at $122.6151 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$321,046.12

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 2,604 shares at $123.2896 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$114,415.98

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 920 shares at $124.3652 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$74,820.28

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 597 shares at $125.3271 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$63,910.17

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 505 shares at $126.5548 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$76,662.26

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 579 shares at $132.4046 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$123,292.33

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 922 shares at $133.7227 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$257,555.28

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 2,004 shares at $128.5206 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$212,454.94

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,644 shares at $129.2305 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$129,175.40

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 990 shares at $130.4802 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$136,092.15

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,035 shares at $131.4900 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$675,681.07

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 5,095 shares at $132.6165 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$327,524.32

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 2,458 shares at $133.2483 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$447,585.68

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 3,335 shares at $134.2086 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$196,063.87

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,447 shares at $135.4968 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$111,475.07

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 817 shares at $136.4444 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001104659-26-115916 · filed 2026-10-14 · View filing →

SEC FORM 4
$15,379.56

PALVELLA THERAPEUTICS, INC. (PVLA)

Acquisition (code M) of 2,154 shares at $7.14 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001104659-26-108930 · filed 2026-09-18 · View filing →

SEC FORM 4
$19,503.84

PALVELLA THERAPEUTICS, INC. (PVLA)

Acquisition (code M) of 2,148 shares at $9.08 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001104659-26-108930 · filed 2026-09-18 · View filing →

SEC FORM 4
$250,772.62

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,659 shares at $151.1589 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001104659-26-108930 · filed 2026-09-18 · View filing →

SEC FORM 4
$150,685.72

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 989 shares at $152.3617 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001104659-26-108930 · filed 2026-09-18 · View filing →

SEC FORM 4
$253,464.58

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,654 shares at $153.2434 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001104659-26-108930 · filed 2026-09-18 · View filing →

SEC FORM 4
$142,506.52

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 954 shares at $149.3779 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$39,556.38

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 263 shares at $150.4045 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$84,742.73

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 560 shares at $151.3263 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$853,036.80

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 5,632 shares at $151.4625 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$937,033.94

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 6,160 shares at $152.1159 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$238,834.44

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,560 shares at $153.099 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$982,035.23

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 6,520 shares at $150.6189 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$694,402.76

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 4,577 shares at $151.7157 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$194,997.29

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,274 shares at $153.0591 per share.

Reporting Person JENKINS GEORGE M · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001104659-26-108022 · filed 2026-09-15 · View filing →

SEC FORM 4
$39,813.60

PALVELLA THERAPEUTICS, INC. (PVLA)

Acquisition (code M) of 313 shares at $127.20 per share.

Reporting Person KIRITSY CHRISTOPHER P · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001104659-26-105494 · filed 2026-09-04 · View filing →

SEC FORM 4
$49,141.00

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 313 shares at $157.00 per share.

Reporting Person KIRITSY CHRISTOPHER P · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001104659-26-105494 · filed 2026-09-04 · View filing →

SEC FORM 4
$15,379.56

PALVELLA THERAPEUTICS, INC. (PVLA)

Acquisition (code M) of 2,154 shares at $7.14 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001104659-26-099222 · filed 2026-08-20 · View filing →

SEC FORM 4
$19,503.84

PALVELLA THERAPEUTICS, INC. (PVLA)

Acquisition (code M) of 2,148 shares at $9.08 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001104659-26-099222 · filed 2026-08-20 · View filing →

SEC FORM 4
$227,085.00

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,500 shares at $151.39 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001104659-26-099222 · filed 2026-08-20 · View filing →

SEC FORM 4
$303,292.20

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 1,998 shares at $151.7979 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001104659-26-099222 · filed 2026-08-20 · View filing →

SEC FORM 4
$61,199.00

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 400 shares at $152.9975 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001104659-26-099222 · filed 2026-08-20 · View filing →

SEC FORM 4
$15,870.16

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 102 shares at $155.5898 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001104659-26-099222 · filed 2026-08-20 · View filing →

SEC FORM 4
$47,344.54

PALVELLA THERAPEUTICS, INC. (PVLA)

Sale of 302 shares at $156.77 per share.

Reporting Person Goin Kathleen · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001104659-26-099222 · filed 2026-08-20 · View filing →